Found: of view, we should make it every doctor’s or every clinical nurse specialist’s business if you have epilepsy

Found: Cave, Chief Safety Officer at the MHRA, said:  Valproate is an effective medicine in the treatment of epilepsy

Found: Valproate medicines are used in treatment of epilepsy and bipolar disorder.

Found: Their father and mother were treated with valproate for epilepsy.

Found: with valproate with those in untreated patients with epilepsy.

Found: blurred 2 (1.5) 0 1 (0.7) 0 Burning sensation 1 (0.7) 0 NR NR Delirium febrile 1 (0.7) 0 NR NR Epilepsy

Found: For example , medicine for epilepsy or depression We need members to be available You

Found: screening in the preceding 12 months EP002 The percentage of patients 18 or over on drug treatment for epilepsy

Found: screening in the preceding 12 months EP002 The percentage of patients 18 or over on drug treatment for epilepsy

Found: screening in the preceding 12 months EP002 The percentage of patients 18 or over on drug treatment for epilepsy

Found: dyscalculia) Neurodivergence (e . g. learning disability, autism, fetal alcohol syndrome, ADHD) Epilepsy

Found: under the care of a medical consultant, for particular conditions such as multiple sclerosis, severe epilepsy

Found: • Paediatric SIGN guideline for epilepsy due out later this year.

Found: A few, however, questioned the inclusion of epilepsy within the scope of the Bill when other neurological

Found: • Chronic Obstructive Pulmonary Disease • Coronary heart disease • Depression • Diabetes • Epilepsy

Found: people long-term (≥8weeks) B-Z use may be considered appropriate, for example, in Parkinson’s disease or epilepsy

Question

To ask the Scottish Government how many epilepsy specialist nurses there have been in each NHS board in each of the past two years.

Answered by Gray, Neil - Cabinet Secretary for Health and Social Care

The information requested on how many epilepsy specialist nurses there have been in each NHS board in each of the past two years is not centrally available.